In focus · trending topic

Real-Time PCR

15 stories · following the connections

Important JAMA Article Underscores Superiority of Precipio’s Liquid Biopsy Core Technology

By Nasdaq OMXApr 3, 2018, 11:38 AM UTC

PositiveID Announces 2017 Highlights and Projects Continued 30% Growth

By Nasdaq OMXJan 10, 2018, 1:00 PM UTC

PositiveID’s ExcitePCR Named Major Player in Molecular Diagnostics Industry Report

By Nasdaq OMXDec 14, 2017, 1:01 PM UTC

PositiveID Announces Highlights for the Third Quarter of 2017

By Nasdaq OMXOct 9, 2017, 12:00 PM UTC

PositiveID’s ExcitePCR Subsidiary CEO to Speak on National Academies of Science, Engineering, and Medicine Panel Today

By Nasdaq OMXSep 18, 2017, 1:00 PM UTC

PositiveID Forms ExcitePCR Subsidiary to Better Position its Firefly Dx for $19 Billion Global Point-of-Care Diagnostics Market

By Nasdaq OMXMay 25, 2017, 12:04 PM UTC

PositiveID Forms ExcitePCR Subsidiary to Better Position its Firefly Dx for $19 Billion Global Point-of-Care Diagnostics Market

By Nasdaq OMXMay 25, 2017, 12:04 PM UTC

PositiveID Forms ExcitePCR Subsidiary to Better Position its Firefly Dx for $19 Billion Global Point-of-Care Diagnostics Market

By Nasdaq OMXMay 25, 2017, 12:04 PM UTC